Rationally combining anti-VEGF therapy with checkpoint inhibitors in hepatocellular carcinoma.
about
Antiangiogenic agents targeting different angiogenic pathways have opposite effects on tumor hypoxia in R-18 human melanoma xenograftsImmunotherapeutic approaches for hepatocellular carcinomaThe Effect of Sunitinib Treatment in Human Melanoma Xenografts: Associations with Angiogenic ProfilesProperdistatin inhibits angiogenesis and improves vascular function in human melanoma xenografts with low thrombospondin-1 expression.A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC).Antiangiogenic activity of vitexicarpine in experimentally induced hepatocellular carcinoma: Impact on vascular endothelial growth factor pathway.Cellular and molecular targets for the immunotherapy of hepatocellular carcinoma.Impact of Different Embolic Agents for Transarterial Chemoembolization (TACE) Procedures on Systemic Vascular Endothelial Growth Factor (VEGF) Levels.Understanding preanalytical variables and their effects on clinical biomarkers of oncology and immunotherapy.Complete Response to the Combination of Pembrolizumab and Sorafenib for Metastatic Hepatocellular Carcinoma: A Case Report.Endostatin reverses immunosuppression of the tumor microenvironment in lung carcinoma.
P2860
Q30855619-2796A80F-C2B7-4A69-BD9F-886BF84F8C93Q33779723-EFD2CF55-3F54-4437-9F80-C07B939A7810Q37627013-3E2A0B6F-8BFA-4A79-82A6-5C070E6AE31DQ37718288-FAC2E71C-B0E4-4C98-B880-996CB98F0600Q38387061-83387490-FF6D-45C9-B62A-5F87535EA30FQ38699011-7AC232FE-2D6B-4AB9-A516-8ACD7039964AQ39358916-F1A7ECFD-E770-4432-9C64-C95C6C1EA7B6Q41181429-D088BFFD-1375-4825-B3FB-F383F22A7E9FQ47273844-EEAD4BED-D26A-4995-A732-3CE6507F6432Q47923931-C32AA5AA-1CEB-455A-A498-0F604E9915D9Q49622371-093E5D6A-A049-40C3-BA16-8B4157B42B2A
P2860
Rationally combining anti-VEGF therapy with checkpoint inhibitors in hepatocellular carcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Rationally combining anti-VEGF ...... s in hepatocellular carcinoma.
@en
type
label
Rationally combining anti-VEGF ...... s in hepatocellular carcinoma.
@en
prefLabel
Rationally combining anti-VEGF ...... s in hepatocellular carcinoma.
@en
P2093
P2860
P356
P1433
P1476
Rationally combining anti-VEGF ...... s in hepatocellular carcinoma.
@en
P2093
Andrew X Zhu
Dan G Duda
P2860
P304
P356
10.2217/IMT.15.126
P577
2016-02-11T00:00:00Z